Neomatrix Therapeutics

TECHNOLOGY SUMMARY

1 — 19

AREA/MATURITY/AWARDS

Primary Application Area: Startup Technology Company

Technology Development Status: IV cNP8 utilizes a peptide (cNP8) engineered to speed healing, minimize scarring, and reduce pain in

Technology Readiness Level:

Vetted Programs/Awards: Congressionally Directed Medical Research Programs (CDMRP), Joint Warfighter Medical Research Program (JWMRP), Defense Medical Research and Development Program (DMRDP), Military Burn Research Program (MBRP)


SHOWCASE SUMMARY

Organization Type: Proven Manufacturability

Website: US

Global Innovation Awardee

MARKET KEYWORDS

Market Keywords: Burns, healing, therapy